Unlike AD, which is characterized by elevated CSF p-tau, PSP shows an inverse correlation between CSF p-tau levels and both disease severity and progression rate, suggesting a mechanistically distinct tau pathology from that observed in AD [81]. Here, MAPT is linked to Alzheimer disease.